Press Release NIH grant to help fast-track Neurodon’s Alzheimer’s drug development research A $2 million grant from the National Institute on Aging at the National Institutes of…ZR6WdqV65YAugust 12, 2020
Press Release New Scientific Advisory Board Member Neurodon Corporation (https://neurodon.net), a pharmaceutical company engaged in the discovery and development of disease-modifying therapeutics…Colleen MaugerFebruary 17, 2020
Press Release Neurodon Welcomes Brunde Broady Neurodon Welcomes Brunde Broady to its Board of Directors Neurodon Corporation announced today the appointment…Colleen MaugerOctober 3, 2019
Press Release SERCA Activator May Improve Memory and Cognition for Alzheimer’s Patients WEST LAFAYETTE, Ind. – A Purdue University graduate and a Purdue Research Park of Northwest…ZR6WdqV65YMay 9, 2019
Press Release Neurodon Receives Funding from Elevate Ventures Neurodon Receives Funding from Elevate Ventures Through the 21st Century Research & Technology Fund …ZR6WdqV65YJanuary 4, 2019
Press Release Neurodon Awarded Phase I NIH STTR Grant Neurodon Awarded Phase I NIH STTR Grant for Alzheimer’s Disease Drug Discovery Neurodon Corporation, an…Colleen MaugerSeptember 24, 2018
Press Release Neurodon Scientists Have Validated a New Way to Halt Brain Cell Loss PRLog -- Neurodon LLC, a leader in disease-modifying treatments for neurodegenerative diseases like Parkinson's, Alzheimer's, and…ZR6WdqV65YFebruary 5, 2018
Press Release Breakthrough Discovery for Parkinson’s Disease Treatment Neurodon LLC has recently published a breakthrough study that paves the way for a new,…ZR6WdqV65YOctober 14, 2016